RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in RVL Pharmaceuticals plc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −11 vs. Q2 2021
- Shares held
- 4.03M
- −795.3K (−16.5%) vs. Q2 2021
- Total value
- $11.9M
- −$2.67M (−18.4%) vs. Q2 2021
- New holders
- 1
- 12 more added
- Sold out
- 12
- 12 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,422,775 | $4.20M | 0.00% | −245,876−14.7% | Reduced |
| Renaissance Technologies LLC | 917,049 | $2.71M | 0.00% | −56,053−5.8% | Reduced |
| Rovida Advisors Inc. | 563,553 | $1.66M | 0.07% | +263,245+87.7% | Added |
| Vanguard Group Inc | 210,434 | $621.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 170,502 | $503.0K | 0.00% | +3,252+1.9% | Added |
| Geode Capital Management, LLC | 146,432 | $431.0K | 0.00% | −9,286−6.0% | Reduced |
| Millennium Management LLC | 127,563 | $376.0K | 0.00% | −32,577−20.3% | Reduced |
| Dimensional Fund Advisors LP | 74,778 | $220.0K | 0.00% | +17,553+30.7% | Added |
| Deutsche Bank AG | 71,103 | $210.0K | 0.00% | +18,149+34.3% | Added |
| Ergoteles LLC | 41,349 | $122.0K | 0.00% | −15,851−27.7% | Reduced |
| State Street Corp | 34,184 | $101.0K | 0.00% | +3,900+12.9% | Added |
| Goldman Sachs Group Inc | 27,120 | $80.0K | 0.00% | −29,193−51.8% | Reduced |
| Northern Trust Corp | 26,157 | $77.0K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 25,920 | $76.0K | 0.00% | −8,938−25.6% | Reduced |
| Zebra Capital Management LLC | 24,384 | $72.0K | 0.09% | 00.0% | Unchanged |
| HRT Financial LP | 22,866 | $67.0K | 0.00% | −13,195−36.6% | Reduced |
| Wells Fargo & Company | 17,010 | $50.0K | 0.00% | +10,000+142.7% | Added |
| Insight Advisors, LLC | 24,800 | $45.0K | 0.01% | 00.0% | Unchanged |
| ProShare Advisors LLC | 13,434 | $40.0K | 0.00% | +2,165+19.2% | Added |
| Nations Financial Group Inc, | 12,500 | $37.0K | 0.01% | +12,500 | New |
| Bank of New York Mellon Corp | 12,078 | $36.0K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 10,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,848 | $23.0K | 0.00% | +1,086+16.1% | Added |
| Bank of America Corp | 6,214 | $18.0K | 0.00% | +3,463+125.9% | Added |
| UBS Group AG | 4,988 | $15.0K | 0.00% | +3,289+193.6% | Added |
| JPMorgan Chase & Co | 4,253 | $13.0K | 0.00% | −33,353−88.7% | Reduced |
| Citigroup Inc | 3,526 | $10.0K | 0.00% | −1,607−31.3% | Reduced |
| Barclays PLC | 2,425 | $7.00K | 0.00% | −2,684−52.5% | Reduced |
| Advisor Group Holdings, Inc. | 1,687 | $5.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,931 | $5.00K | 0.00% | +170+9.7% | Added |
| O'Shaughnessy Asset Management, LLC | 1,299 | $4.00K | 0.00% | 00.0% | Unchanged |
| Penserra Capital Management LLC | 1,440 | $4.00K | 0.00% | +10+0.7% | Added |
| The PNC Financial Services Group, Inc. | 700 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 43 | $127 | 0.00% | −4,304−99.0% | Reduced |
| Daiwa Securities Group Inc. | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −339,129−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −80,827−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −61,991−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −57,958−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −53,724−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −35,028−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −27,966−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,077−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −1,020−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −730−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −111−100.0% | Sold out |